Cell Therapy

India's first off-the-shelf cell therapy treatment for knee osteoarthritis

One injection will cost Rs 1.25 lakh with effects lasting for two years or more

Cell-therapy treatment for cancer in India may come at 10% of US cost

Pharma firms and start-ups working to launch it within 2 yrs

Laurus Labs signs pact to acquire 26.62 % stake in ImmunoACT

Laurus labs investment in ImmunoACT is part of the larger strategy to strengthen biologics business of the firm

Covid-19 linked diseases in children causing changes in blood cells: Study

They said this disease can cause inflammation of heart muscle if left untreated, and is the leading cause of acquired heart disease in children in developed nations

Gene therapy to conquering hepatitis C: A decade of medical breakthroughs

Putting aside prices for a moment, it's been an exciting period for medical progress

Regrow's cell therapy product gets orphan drug status from USFDA

Start-up in talks with MNCsto out-license Ossgrow for developed markets